Browsing by Author Wu, Yi Long

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 3 of 3
TitleAuthor(s)Issue Date
 
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study
Journal:Journal of Thoracic Oncology
Wu, Yi LongKim, Hye RyunSoo, Ross A.Zhou, QingAkamatsu, HiroakiChang, Gee ChenChiu, Chao HuaHayashi, HidetoshiKim, Sang WeGoto, YasushiKato, TerufumiZhou, JianyingLee, Victor Ho FunNishio, MakotoHan, BaohuiKim, Dong WanLu, ShunPolli, AnnaMartini, Jean FrançoisToffalorio, FrancescaWong, Chew HooiMok, Tony
28-Feb-2025
 
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
Journal:Journal of Clinical Oncology
Spigel, David R.Faivre-Finn, CorinneGray, Jhanelle E.Vicente, DavidPlanchard, DavidPaz-Ares, LuisVansteenkiste, Johan F.Garassino, Marina C.Hui, RinaQuantin, XavierRimner, AndreasWu, Yi LongÖzgüroǧlu, MustafaLee, Ki H.Kato, TerufumiDe Wit, MaikeKurata, TakayasuReck, MartinCho, Byoung C.Senan, SureshNaidoo, JarushkaMann, HelenNewton, MichaelThiyagarajah, PirunthaAntonia, Scott J.
2022
 
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042
Proceeding/Conference:JTO Clinical and Research Reports
Mansfield, Aaron S.Herbst, Roy S.de Castro, GilbertoHui, RinaPeled, NirKim, Dong WanNovello, SilviaSatouchi, MiyakoWu, Yi LongGaron, Edward B.Reck, MartinRobinson, Andrew G.Samkari, AymanPiperdi, BilalEbiana, VictoriaLin, JianxinMok, Tony S.K.
2021
Showing results 1 to 3 of 3